Noxopharm (ASX:NOX) Other Long Term Assets : A$-0.00 Mil (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Noxopharm Other Long Term Assets?

Noxopharm's other long-term assets for the quarter that ended in Dec. 2023 was A$-0.00 Mil.

Noxopharm's quarterly other long-term assets declined from Dec. 2022 (A$0.13 Mil) to Jun. 2023 (A$-0.00 Mil) but then stayed the same from Jun. 2023 (A$-0.00 Mil) to Dec. 2023 (A$-0.00 Mil).

Noxopharm's annual other long-term assets stayed the same from Jun. 2021 (A$0.12 Mil) to Jun. 2022 (A$0.12 Mil) but then declined from Jun. 2022 (A$0.12 Mil) to Jun. 2023 (A$-0.00 Mil).

Noxopharm Other Long Term Assets Historical Data

The historical data trend for Noxopharm's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noxopharm Other Long Term Assets Chart

Noxopharm Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Long Term Assets

Get a 7-Day Free Trial

0.12

0.35

0.12

Noxopharm Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Long Term Assets	Get a 7-Day Free Trial										0.12	0.12	0.13	-	-

Noxopharm Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Noxopharm (ASX:NOX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noxopharm Ltd (ASX:NOX) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

NOXOF:USA

Address

60 Linksley Ave, Glenhaven, NSW, AUS, 2156

Website

https://www.noxopharm.com

Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.

Noxopharm (ASX:NOX) Headlines

No Headlines